Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_assertion type Assertion NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_head.
- NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_assertion description "[study showed that ovarian cancer cell lines expressiing cytoplasmic maspin are more sensitive to cisplatin and that cytoplasmic and nuclear maspin expressing ovarian carcinoma patients have longer survival rates ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_provenance.
- NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_assertion evidence source_evidence_literature NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_provenance.
- NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_assertion SIO_000772 16633061 NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_provenance.
- NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_assertion wasDerivedFrom lhgdn-20090331 NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_provenance.
- NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_assertion wasGeneratedBy ECO_0000203 NP216784.RAgscm6YhT3myaWocsX1ATtNcTob9UTWD3IMWQe2nIPSo130_provenance.